Skip to main content
. 2017 Sep 7;77(15):1468–1477. doi: 10.1002/pros.23407

Figure 2.

Figure 2

CD169 (brown) immunostaining of regional lymph nodes from prostate cancer patients. Representative pictures of low (upper panel) or high (lower panel) CD169 score